基本信息
views: 38
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Prof. Andres Pichon-Riviere MD Msc PhD, is a Physician, graduated from the University of Buenos Aires (UBA). He has a Master of Sciences in Clinical Epidemiology from Harvard University and a PhD in Public Health (UBA). He received training in disease modeling and economic evaluation methods at University or York and the London School of Hygiene and Tropical Medicine.
Andres is the Executive Director and Director of the Health Technology Assessment (HTA) and Economic Evaluations Department of the Institute for Clinical Effectiveness and Health Policy (IECS) and Director of the WHO/PAHO collaborating center in HTA. The IECS is an independent, non-for-profit organization devoted to research, education and technical support with the main goal of improving efficiency, equity, and quality of health care systems and policies in Argentina and Latin America. IECS is one of the leading Latin American Health Technology Assessment (HTA) Agencies, with more than 400 HTA reports and economic evaluations published in the last fifteen years and indexed in the Centre for Reviews and Dissemination Database. He is also Professor of Public Health at the University of Buenos Aires, researcher at the National Scientific and Technical Research Council (CONICET), and Director of the courses of HTA for Decision Makers, HTA Postgraduate Course, and Economic Evaluation Modeling Introductory and Advanced Courses.
He has conducted several training, research and implementation projects in HTA and health economic evaluations in cooperation with government agencies, academic and private institutions in Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, El Salvador, Ecuador, Honduras, Mexico, Panama, Peru, Uruguay, and Venezuela. In 2008 was awarded the Global Health Leadership Award from the Global Health Research Initiative to promote HTA in Latin America.
He was Vice-Chair of the International Network of Agencies for Health Technology Assessment (INAHTA) between 2010 and 2014, and member of the board of Directors of Health Technology Assessment International (HTAi) between 2012 and 2015.
His recent work has involved the development of priority setting mechanisms and health benefits packages, and the establishment and training of health technology assessment agencies in developing countries. His most recent research has focused on the cost-effectiveness of vaccines, public health interventions, and oncologic drugs; and in the analysis of the health and economic impact of public policies in the area of chronic diseases.
Research Interests
Papers共 178 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Adolfo Rubinstein, Federico Filippini,Adrian Santoro,Alejandro L. Lopez Osornio,Ariel L. Bardach, Emiliano Navarro, Cintia Cejas,Sebastian Bauhoff,Federico Augustovski,Andres L. Pichon-Riviere,Eduardo L. Levy Yeyati
Andrea Alcaraz, Elena Lazo,Agustin Casarini, Federico Rodriguez-Cairoli,Federico Augustovski,Ariel Bardach,Lucas Perelli,Alfredo Palacios,Andres Pichon-Riviere,Natalia Espinola
FRONTIERS IN PUBLIC HEALTH (2024): 1321319-1321319
VALUE IN HEALTHno. 5 (2024): 570-577
Cost Effectiveness and Resource Allocationno. 1 (2023): 21-21
International journal of technology assessment in health careno. 1 (2023): e73-e73
Revista peruana de medicina experimental y salud publicano. 1 (2023): 86-93
Tobacco Controlpp.tc-057618, (2023)
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobaccono. 11 (2023): 1736-1743
Revista panamericana de salud publica = Pan American journal of public health (2023): e80-e80
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn